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Abstract
Background: Acute myocardial infarction (MI) following anaphylaxis is rare, especially in subjects
with normal coronary arteries. The exact pathogenetic mechanism of MI in anaphylaxis remains
unclear.
Case presentation: The case of a 32-year-old asthmatic male with systemic anaphylaxis, due to
oral intake of 500 mg amoxycillin, complicated by acute ST-elevation MI is the subject of this report.
Following admission to the local Health Center and almost simultaneously with the second dose of
subcutaneous epinephrine (0.2 mg), the patient developed acute myocardial injury. Coronary
arteriography, performed before discharge, showed no evidence of obstructive coronary artery
disease. In vivo allergological evaluation disclosed strong sensitivity to amoxycillin and the minor
(allergenic) determinants of penicillin.
Conclusion: Acute ST-elevation MI is a rare but potential complication of anaphylactic reactions,
even in young adults with normal coronary arteries. Coronary artery spasm appears to be the main
causative mechanism of MI in the setting of "cardiac anaphylaxis". However, on top of the
vasoactive reaction, a thrombotic occlusion, induced by mast cell-derived mediators and facilitated
by prolonged hypotension, cannot be excluded as a possible contributory factor.
Background
Acute myocardial infarction (MI) complicating anaphy-
laxis induced by drugs or other chemicals is uncommon
and only sporadic cases have been reported [1-9]. The
underlying pathogenetic mechanisms have not been fully
elucidated. The case of a 32-year-old man with normal
coronary arteries, who developed acute MI following
amoxycillin-induced anaphylaxis, is the subject of this
report. The underlying pathogenetic mechanisms are also
discussed and the relative literature is reviewed.
Case presentation
A 32-year-old man was admitted to the emergency room
of the local Health Center because of anaphylaxis, which
developed 2 hours and 15 minutes after the ingestion of
amoxycillin (500 mg), prescribed by his dentist. Prodro-
mal signs of anaphylaxis (flushing, pruritus, warmth, urti-
caria) reportedly occurred about 15 minutes before the
onset of symptoms from other systems. Ten days earlier
the patient, an asthmatic since childhood, had completed
a 4-day course of amoxycillin (500 mg TID) without any
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factors for coronary artery disease.
On admission the patient was in acute distress. He was
complaining of dizziness, blurred vision, dyspnea and
abdominal pain. Initial examination revealed an obese
man (Weight = 130 kg, Body Mass Index = 38 kg/m2) with
generalized erythema, angioedema, cyanosis and diffuse
wheezing; the systolic blood pressure was 70 mmHg and
the pulse rate 120 bpm. The patient was then connected
to a cardiac monitor, which showed sinus tachycardia
(approximately 140 bpm) without ST-segment and T
wave abnormalities (Fig. 1A). Pulse oxymetry demon-
strated an oxygen saturation (SpO2) of 90%.
Epinephrine (0.3 mg or 0.3 ml of a dilution 1:1000) was
injected subcutaneously (SC); dimethindene (4 mg) and
hydrocortizone (500 mg) were administered intrave-
nously (IV) in slow infusion. Nebulized salbutamol and
supplemental oxygen were given as well. Normal saline
with 50 mg ranitidine hydrochloride and Ringer's solu-
tion were infused through separate intravenous lines.
Due to unsatisfactory clinical response (persistence of
hypotension and tachycardia, despite improvement of the
pulmonary signs) a second dose of epinephrine (0.2 mg)
was given SC 20 minutes later. Almost simultaneously
with the administration of the second dose of epine-
phrine, ST-segment elevation appeared on the monitor
(Fig. 1B) and the patient complained of substernal chest
pain. A 12-lead electrocardiogram (ECG) showed ST seg-
ment elevation in leads II, III, aVF, and V3 to V6 (Fig. 2). A
single dose of 325 mg acetylsalicylic acid was given per os;
heparin (5000 UI) and pethidine hydrochloride (25 mg)
were administered IV. An hour later the patient was hemo-
dynamically stable. The arterial blood pressure was 125/
90 mmHg and SpO2 rose to 96%. However, the chest
pain persisted and nitroglycerin titrated at a dose of 25 µg/
min was infused IV, without complete symptom relief. At
Lead II monitor strip recorded shortly after admission (A) and at the chest pain onset (B)Figure 1
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Unit (CCU) of the nearest general hospital.
Treatment in the CCU included thrombolysis with
reteplase – administered according to the standard proto-
col – 2 hours after the onset of chest discomfort, which
according to the established clinical and electrocardio-
graphic criteria was considered successful [10]. The peak
levels of serum troponin I and creatine phosphokinase
were 45.5 ng/ml (normal = 0–2 ng/ml) and 575 U/L (nor-
mal = 25–195 U/L), respectively; while the MB fraction
was 77 U/L (normal = 0–24 U/L). The rest of the labora-
tory results, including serum cholesterol, LDL, HDL, Lpa
and triglycerides, were within normal limits. An ECG per-
formed before discharge showed complete loss of poten-
tials in leads III and aVF and partial loss of potentials with
a small q wave in lead II (Fig. 3). An echocardiographic
study performed on the 5th hospital day showed preserved
systolic function (ejection fraction 60%) without wall
motion abnormalities. Left (Fig. 4) and right (Fig. 5) cor-
onary angiography showed no evidence of obstructive
coronary artery disease; left ventriculography was normal
as well. The patient recovered completely and was dis-
charged a week after admission. He was referred to the
adult Allergology Center of our area performing diagnos-
tic work up for drug allergy.
Prick skin tests (PST) were performed using penicilloyl
polylysine (PPL), and minor determinant mixute (MDM)
[supplied as Allergopen by Allergopharma (Reinbeck,
Germany)]; amoxycillin, ampicillin and cefamandole
solutions were also used (concentration 20 mg/ml) for
PST. PST were strongly positive [4+ reaction (on a scale of
1–4) i.e. wheal >5 mm in diameter with pseudopodes,
with no reaction at all to the diluent control] to amoxycil-
lin and ampicillin. Intradermal tests were performed only
to PPL, MDM (dilution 1/10) and cefamandole (0.2 mg/
ml and 2 mg/ml) and resulted in strongly positive
reaction (4+) only to the MDM. Circulating specific IgE to
penicillin V, penicillin G, amoxycillin, ampicillin and
ECG recorded during chest painFigur  2
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Sweden).
Discussion
Anaphylactic reactions may trigger cardiovascular events,
including MI [1-9], primarily in subjects with underlying
ischemic heart disease [1,2,4,7,9] and rarely in individuals
with normal coronary arteries [3,5,6,8]. Cardiovascular
complications in the setting of anaphylaxis rarely occur in
subjects less than 35 years old [11].
Acute coronary syndromes following antibiotic-induced
anaphylaxis is uncommon and only few cases have been
reported so far [1,4,12-14]. To our knowledge, only one
case of amoxycillin-induced anaphylaxis complicated
with acute MI has been documented in a 62-year-old man
with underlying coronary artery disease [4].
Evidence that the human heart is the target as well as the
site of anaphylaxis is constantly growing. A number of
studies by Marone et al [15,16] and others [17] have dem-
onstrated mast cells within the human heart; they are stra-
tegically located perivascularly, in close proximity to
myocytes, in the arterial intima and the shoulder region of
atheromas. Cardiac mast cells express on their surface
ECG recorded on hospital day 4thFigur  3
ECG recorded on hospital day 4th.
Left coronary angiogramFigure 4
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tors [18]. Mast cells activation through immunological
and non-specific (non-immunological) stimuli leads to
the release of a variety of vasoactive and pro-inflamma-
tory mediators, preformed or de novo synthesized (hista-
mine, prostaglandins, leukotrienes, enzymes, cytokines
and others) [15,19]. Coronary spasm, which is proposed
as the main underlying mechanism of allergy-induced
coronary syndromes [5,11,13,14,20,21], can be caused,
directly or indirectly, by potent vasoactive mast cell-
derived mediators such as histamine, prostaglandin D2,
thromboxane, cysteinyl leukotrienes [15,18,22-24]. In
addition, mast cells are likely to affect coagulation and
fibrinolysis at different levels through enzymes and medi-
ators they secrete [15]. Therefore, mediators from perivas-
cular and interstitial cardiac mast cells – as well as those
reaching the heart from the pulmonary circulation –
Right coronary angiogramF ure 5
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and thrombus formation [15,25].
In the present case, the temporal sequence of events sug-
gests that cardiac anaphylaxis was the triggering factor of
MI. We propose that prolonged coronary vasospasm
induced by vasoactive and inflammatory mediators,
released during anaphylaxis, was the main causative
mechanism. However, in view of the persistence of chest
pain following IV nitroglycerin infusion, and its complete
resolution promptly after IV thrombolysis, a thrombotic
vascular occlusion, on top of the vasospastic reaction, can-
not be excluded. The latter is also supported by the pro-
longed systemic hypotension, which, as it has been
emphasized in previously reported cases [26], probably
caused further reduction of the myocardial perfusion,
thus, favoring in situ thrombus formation and subsequent
coronary artery occlusion. In acute MI cases, presenting to
centers with cardiac catheterization facilities, urgent coro-
nary arteriography appears as the management strategy of
choice for the final diagnosis. However, in the setting of
acute anaphylaxis, this might not be the wisest choice,
particularly in cases, like the present one, in which the
offending allergen had been administered orally. Moreo-
ver, continuous or delayed allergen absorption could fur-
ther aggravate anaphylaxis, and a late phase reaction
represents a potential risk in all anaphylactic reactions.
Finally, no bibliographical data are available concerning
the tolerability of IV administered contrast agents in
patients who have suffered a recent episode of severe sys-
temic anaphylaxis.
The administration of epinephrine – a life saving agent in
cases of anaphylaxis – has been implicated as a cause of
acute MI in a limited number of reports [27,28]. In the
present case, however, it appears unlikely that exogenous
epinephrine was the initiating event for the following rea-
sons: a) the first epinephrine dose (0.3 mg) was rather low
to induce significant vasoconstriction in a subject with a
body weight of 130 kg, b) the mode of administration
(SC) is considered the safest in this regard, c) the second
dose (0.2 mg), administered at a safe interval (20 min)
after the first one, does not seem to be involved since its
injection coincided with the onset of chest pain, before
any anticipated drug absorption. On the contrary, in the
above quoted cases [27,28] the epinephrine-induced MI
developed 5–15 minutes post injection. Moreover, the
possibility of inadvertent intravenous administration of
epinephrine appears improbable, since no blood was
withdrawn in the syringe before drug injection. However,
one might argue that the exogenous epinephrine could
have aggravated a pre-existing coronary spasm, induced
by mast cell-derived mediators. Hence, the precise effect
of epinephrine in this clinical setting remains a matter of
speculation.
The allergological evaluation performed in our patient
showed strong sensitivity to amoxycillin and to the minor
determinants, which are the allergenic epitopes associated
with systemic anaphylaxis. The negative CAP results do
not negate the in vivo findings, since it is well established
that the in vitro techniques are not as sensitive as skin
tests. Furthermore, CAP detects antibodies against the
major determinants of penicillins (involved pathogeneti-
cally in penicillin-induced urticaria) and not to the minor
ones, which are implicated in systemic anaphylaxis. For
technical reasons, relating to both the Allergology Center
and the patient's professional obligations as well as resi-
dence distance, the allergological work up was completed
6 months later; such a delay might also have contributed
to the negative in vitro findings.
Conclusion
Acute ST-elevation MI is a rare but potential complication
of anaphylactic reactions, even in young adults with nor-
mal coronary arteries. Physicians should be alert for such
a complication in order to diagnose it early and treat
properly.
It is fairly well established that that human heart can be
both, the site and the target of severe anaphylaxis; in this
setting cardiac mast cells – activated and releasing multi-
ple vasoactive mediators – play an important role in
pathogenesis of cardiac complications [16-18].
In the above case, mediator-induced coronary artery
spasm was the main, but probably not the exclusive caus-
ative mechanism of anaphylaxis-related MI. The throm-
botic vascular occlusion, induced by inflammatory
mediators and facilitated by prolonged hypotension, can-
not be excluded as a possible contributory factor.
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